These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9067917)

  • 1. Sickle cell anemia causes a distinct pattern of glomerular dysfunction.
    Guasch A; Cua M; You W; Mitch WE
    Kidney Int; 1997 Mar; 51(3):826-33. PubMed ID: 9067917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection and the course of glomerular injury in patients with sickle cell anemia.
    Guasch A; Cua M; Mitch WE
    Kidney Int; 1996 Mar; 49(3):786-91. PubMed ID: 8648921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early glomerular dysfunction in patients with sickle cell anemia.
    Schmitt F; Martinez F; Brillet G; Giatras I; Choukroun G; Girot R; Bachir D; Galacteros F; Lacour B; Grünfeld JP
    Am J Kidney Dis; 1998 Aug; 32(2):208-14. PubMed ID: 9708603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia.
    Yee ME; Lane PA; Archer DR; Joiner CH; Eckman JR; Guasch A
    Blood Cells Mol Dis; 2018 Mar; 69():65-70. PubMed ID: 28951038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early glomerular dysfunction in human renal allografts.
    Zayas CF; Guasch A
    Kidney Int; 2001 Nov; 60(5):1938-47. PubMed ID: 11703613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of exercise on glomerular passage of macromolecules in patients with diabetic nephropathy and in healthy subjects.
    Ala-Houhala I
    Scand J Clin Lab Invest; 1990 Feb; 50(1):27-33. PubMed ID: 1690442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional nature of glomerular injury in progressive diabetic glomerulopathy.
    Tomlanovich S; Deen WM; Jones HW; Schwartz HC; Myers BD
    Diabetes; 1987 May; 36(5):556-65. PubMed ID: 2436961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic renal failure in sickle cell disease: A retrospective analysis of 100 adults sickle cell patients from black Africa].
    Ackoundou-N'Guessan C; Guei CM; Lagou DA; Gbekedi S; Tia MW; Coulibaly PA; Nzoue S; Konan S; Koffi G; Gnionsahe DA
    Nephrol Ther; 2016 Jun; 12(3):149-55. PubMed ID: 26653399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased glomerular permeability in patients with nephropathia epidemica caused by Puumala hantavirus.
    Ala-Houhala I; Koskinen M; Ahola T; Harmoinen A; Kouri T; Laurila K; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 2002 Feb; 17(2):246-52. PubMed ID: 11812874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset.
    Myers BD; Nelson RG; Williams GW; Bennett PH; Hardy SA; Berg RL; Loon N; Knowler WC; Mitch WE
    J Clin Invest; 1991 Aug; 88(2):524-30. PubMed ID: 1864963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular function and hyperuricaemia in sickle cell disease.
    Morgan AG; De Ceulaer K; Serjeant GR
    J Clin Pathol; 1984 Sep; 37(9):1046-9. PubMed ID: 6470183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of colloid volume expansion on glomerular barrier size-selectivity in humans.
    Shemesh O; Deen WM; Brenner BM; McNeely E; Myers BD
    Kidney Int; 1986 Apr; 29(4):916-23. PubMed ID: 3712975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
    Ruggenenti P; Mosconi L; Sangalli F; Casiraghi F; Gambara V; Remuzzi G; Remuzzi A
    Kidney Int; 1999 Mar; 55(3):984-94. PubMed ID: 10027935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular hemodynamics in severe obesity.
    Chagnac A; Weinstein T; Korzets A; Ramadan E; Hirsch J; Gafter U
    Am J Physiol Renal Physiol; 2000 May; 278(5):F817-22. PubMed ID: 10807594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis.
    Guasch A; Hashimoto H; Sibley RK; Deen WM; Myers BD
    Am J Physiol; 1991 May; 260(5 Pt 2):F728-37. PubMed ID: 1709791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional response of healthy and diseased glomeruli to a large, protein-rich meal.
    Chan AY; Cheng ML; Keil LC; Myers BD
    J Clin Invest; 1988 Jan; 81(1):245-54. PubMed ID: 3275694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal dysfunction in patients with sickle cell anemia or sickle cell trait.
    Sesso R; Almeida MA; Figueiredo MS; Bordin JO
    Braz J Med Biol Res; 1998 Oct; 31(10):1257-62. PubMed ID: 9876295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules.
    Bohrer MP; Baylis C; Robertson CR; Brenner BM; Troy JL; Willis WT
    J Clin Invest; 1977 Jul; 60(1):152-61. PubMed ID: 874080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature of the glomerular capillary injury in human membranous glomerulopathy.
    Shemesh O; Ross JC; Deen WM; Grant GW; Myers BD
    J Clin Invest; 1986 Mar; 77(3):868-77. PubMed ID: 2419362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
    Morelli E; Loon N; Meyer T; Peters W; Myers BD
    Diabetes; 1990 Jan; 39(1):76-82. PubMed ID: 1698674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.